| Date | May 2015 | Marks available | 1 | Reference code | 15M.3.SL.TZ1.18 |
| Level | Standard level | Paper | Paper 3 | Time zone | Time zone 1 |
| Command term | Identify | Question number | 18 | Adapted from | N/A |
Question
Identify one risk associated with gene therapy.
Markscheme
a. stimulate autoimmune response/tissue rejection / infection resulting from vector;
b. cancer/oncogenes / overexpression of gene;
Do not accept death as a response
Examiners report
Candidates recognised that cancer was a potential risk factor of gene therapy.
Syllabus sections
Option B: Biotechnology and bioinformatics » Option B: Biotechnology and bioinformatics (Additional higher level topics) » B.4 Medicine
Show 36 related questions
